Intravenous Iron Dextran as a Component of Anemia Management in Chronic Kidney Disease: A Report of Safety and Efficacy

Table 3

Parameter comparison at three evaluation points in oral iron group.

Parameter	Evaluation days	Group means ± SD		𝑃 value
Hb (g/dL)	Baseline versus day 30	10.9 ± 1.2	11.1 ± 1.3	0.0258
	Baseline versus day 60	10.9 ± 1.2	11.3 ± 1.2	0.0003
	Day 30 versus day 60	11.1 ± 1.3	11.3 ± 1.2	0.0458
TSAT%	Baseline versus day 30	23.2 ± 5.8	24.0 ± 7.3	0.3318
	Baseline versus day 60	23.2 ± 5.8	25.0 ± 8.4	0.0401
	Day 30 versus day 60	24.0 ± 7.3	25.0 ± 8.4	0.2889
	Baseline versus day 30	216.7 ± 146.0	221.9 ± 167.0	0.4722
Ferritin (ng/mL)	Baseline versus day 60	216.7 ± 146.0	220.2 ± 213.5	0.8339
	Day 30 versus day 60	221.9 ± 167.0	220.2 ± 213.5	0.9215